These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 25723374)

  • 1. Paraoxonase and arylesterase activities in patients with papillary thyroid cancer.
    Korkmaz H; Tabur S; Özkaya M; Aksoy N; Yildiz H; Akarsu E
    Scand J Clin Lab Invest; 2015 May; 75(3):259-64. PubMed ID: 25723374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum paraoxonase and arylesterase activities in patients with epithelial ovarian cancer.
    Camuzcuoglu H; Arioz DT; Toy H; Kurt S; Celik H; Erel O
    Gynecol Oncol; 2009 Mar; 112(3):481-5. PubMed ID: 19101714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum paraoxonase activity and oxidative stress in patients with adult nephrotic syndrome.
    Soyoral YU; Aslan M; Emre H; Begenik H; Erdur FM; Turkel A; Selek S; Erkoc R
    Atherosclerosis; 2011 Sep; 218(1):243-6. PubMed ID: 21723555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidative status and serum PON1 activity in beta-thalassemia minor.
    Selek S; Aslan M; Horoz M; Gur M; Erel O
    Clin Biochem; 2007 Mar; 40(5-6):287-91. PubMed ID: 17296173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of serum paraoxonase and arylesterase activity in patients with endometrial cancer.
    Arioz DT; Camuzcuoglu H; Toy H; Kurt S; Celik H; Erel O
    Eur J Gynaecol Oncol; 2009; 30(6):679-82. PubMed ID: 20099504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paraoxonase and arylesterase activities in fibromyalgia.
    Altindag O; Gur A; Calgan N; Soran N; Celik H; Selek S
    Redox Rep; 2007; 12(3):134-8. PubMed ID: 17623520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of paraoxonase activities in patients with knee osteoarthritis.
    Soran N; Altindag O; Cakir H; Celik H; Demirkol A; Aksoy N
    Redox Rep; 2008; 13(5):194-8. PubMed ID: 18796237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum paraoxonase-1 activity in Helicobacter pylori infected subjects.
    Aslan M; Nazligul Y; Horoz M; Bolukbas C; Bolukbas FF; Gur M; Celik H; Erel O
    Atherosclerosis; 2008 Jan; 196(1):270-274. PubMed ID: 17125774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of paraoxonase and arylesterase activities in patients with iron deficiency anemia.
    Aslan M; Kosecik M; Horoz M; Selek S; Celik H; Erel O
    Atherosclerosis; 2007 Apr; 191(2):397-402. PubMed ID: 16684543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paraoxonase and arylesterase activities in coronary artery disease.
    Gur M; Aslan M; Yildiz A; Demirbag R; Yilmaz R; Selek S; Erel O; Ozdogru I
    Eur J Clin Invest; 2006 Nov; 36(11):779-87. PubMed ID: 17032345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum paraoxonase, arylesterase activity and oxidative status in patients with obstructive sleep apnea syndrome (OSAS).
    Baysal E; Taysi S; Aksoy N; Uyar M; Celenk F; Karatas ZA; Tarakcioglu M; Bilinç H; Mumbuç S; Kanlikama M
    Eur Rev Med Pharmacol Sci; 2012 Jun; 16(6):770-4. PubMed ID: 22913209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PON1 activity and total oxidant status in patients with active pulmonary tuberculosis.
    Selek S; Cosar N; Kocyigit A; Erel O; Aksoy N; Gencer M; Gunak F; Aslan M
    Clin Biochem; 2008 Feb; 41(3):140-4. PubMed ID: 18154731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum calprotectin: a new potential biomarker for thyroid papillary carcinoma.
    Tabur S; Korkmaz H; Özkaya M; Elboğa U; Tarakçıoglu M; Aksoy N; Akarsu E
    Tumour Biol; 2015 Sep; 36(10):7549-56. PubMed ID: 25916207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased paraoxonase and arylesterase activities in the pathogenesis of future atherosclerotic heart disease in women with gestational diabetes mellitus.
    Camuzcuoglu H; Toy H; Cakir H; Celik H; Erel O
    J Womens Health (Larchmt); 2009 Sep; 18(9):1435-9. PubMed ID: 19698032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paraoxonase and arylesterase levels in autoimmune thyroid diseases.
    Korkmaz H; Tabur S; Ozkaya M; Oguz E; Elboga U; Aksoy N; Akarsu E
    Redox Rep; 2016 Sep; 21(5):227-31. PubMed ID: 26795296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of the role of 8-OHdG and oxidative stress in papillary thyroid carcinoma.
    Tabur S; Aksoy ŞN; Korkmaz H; Ozkaya M; Aksoy N; Akarsu E
    Tumour Biol; 2015 Apr; 36(4):2667-74. PubMed ID: 25434875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum paraoxonase and arylesterase activities for the evaluation of patients with chronic hepatitis.
    Aslan M; Horoz M; Nazligul Y; Bolukbas C; Bolukbas FF; Selek S; Aksoy N; Erel O
    Int J Clin Pract; 2008 Jul; 62(7):1050-5. PubMed ID: 17887991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidant/antioxidant status in cases of snake bite.
    Zengin S; Al B; Yarbil P; Taysi S; Bilinc H; Yildirim C; Aksoy N
    J Emerg Med; 2013 Jul; 45(1):39-45. PubMed ID: 23623287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paraoxonase-1 activity and oxidative status in patients with knee osteoarthritis and their relationship with radiological and clinical parameters.
    Ertürk C; Altay MA; Selek S; Koçyiğit A
    Scand J Clin Lab Invest; 2012 Sep; 72(5):433-9. PubMed ID: 22616668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PON1 status in haemodialysis patients and the impact of hepatitis C infection.
    Horoz M; Aslan M; Selek S; Koylu AO; Bolukbas C; Bolukbas FF; Celik H; Erel O
    Clin Biochem; 2007 Jun; 40(9-10):609-14. PubMed ID: 17335792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.